US FDA reconstitutes advisory panel on medical imaging drugs
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration's drug evaluation unit has re-established its Medical Imaging Drugs Advisory Committee that was disbanded in 20021,2.